Severe	severe	O	O	O	O
ocular	ocular	O	O	O	O
and	and	O	O	O	O
orbital	orbital	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
after	after	O	O	O	O
intracarotid	intracarotid	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
carboplatin	carboplatin	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
recurrent	recurrent	O	O	O	O
glioblastomas	glioblastomas	O	O	OTHERS	I
.	.	O	O	O	O

BACKGROUND	background	O	O	O	O
:	:	O	O	O	O
Glioblastoma	glioblastoma	O	DISEASE	OTHERS	I
is	is	O	O	O	O
a	a	O	O	O	O
malignant	malignant	O	O	OTHERS	I
tumor	tumor	O	DISEASE	OTHERS	I
that	that	O	O	O	O
occurs	occurs	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
cerebrum	cerebrum	O	O	O	O
during	during	O	O	O	O
adulthood	adulthood	O	O	O	O
.	.	O	O	O	O

With	with	O	O	O	O
current	current	O	O	O	O
treatment	treatment	O	O	O	O
regimens	regimens	O	O	O	O
including	including	O	O	O	O
combined	combined	O	O	O	O
surgery	surgery	O	O	O	O
,	,	O	O	O	O
radiation	radiation	O	O	O	O
and	and	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
average	average	O	O	O	O
life	life	O	O	O	O
expectancy	expectancy	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
patients	patients	O	O	O	O
is	is	O	O	O	O
limited	limited	O	O	O	O
to	to	O	O	O	O
approximately	approximately	O	O	O	O
1	1	O	O	O	O
year	year	O	O	O	O
.	.	O	O	O	O

Therefore	therefore	O	O	O	O
,	,	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
glioblastoma	glioblastoma	O	DISEASE	OTHERS	I
sometimes	sometimes	O	O	O	O
have	have	O	O	O	O
intracarotid	intracarotid	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
carcinostatics	carcinostatics	O	O	O	O
added	added	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
treatment	treatment	O	O	O	O
regimen	regimen	O	O	O	O
.	.	O	O	O	O

Generally	generally	O	O	O	O
,	,	O	O	O	O
carboplatin	carboplatin	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
said	said	O	O	O	O
to	to	O	O	O	O
have	have	O	O	O	O
milder	milder	O	O	O	O
side	side	O	O	O	O
effects	effects	O	O	O	O
than	than	O	O	O	O
cisplatin	cisplatin	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
whose	whose	O	O	O	O
ocular	ocular	O	O	O	O
and	and	O	O	O	O
orbital	orbital	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
are	are	O	O	O	O
well	well	O	O	O	O
known	known	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
experienced	experienced	O	O	O	O
a	a	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
severe	severe	O	O	O	O
ocular	ocular	O	O	O	O
and	and	O	O	O	O
orbital	orbital	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
after	after	O	O	O	O
intracarotid	intracarotid	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
carboplatin	carboplatin	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
which	which	O	O	O	O
is	is	O	O	O	O
infrequently	infrequently	O	O	O	O
reported	reported	O	O	O	O
.	.	O	O	O	O

CASE	case	O	O	O	O
:	:	O	O	O	O
A	a	O	O	O	O
58-year-old	58-year-old	O	O	O	O
man	man	O	O	O	O
received	received	O	O	O	O
an	an	O	O	O	O
intracarotid	intracarotid	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
carboplatin	carboplatin	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
recurrent	recurrent	O	O	O	O
glioblastomas	glioblastomas	O	O	OTHERS	I
in	in	O	O	O	O
his	his	O	O	O	O
left	left	O	O	O	O
temporal	temporal	O	O	O	O
lobe	lobe	O	O	O	O
.	.	O	O	O	O

He	he	O	O	O	O
complained	complained	O	O	O	O
of	of	O	O	O	O
pain	pain	O	DISEASE	OTHERS	I
and	and	O	O	O	O
visual	visual	O	O	OTHERS	I
disturbance	disturbance	O	O	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
ipsilateral	ipsilateral	O	O	O	O
eye	eye	O	O	O	O
30	30	O	O	O	O
h	h	CHEMICALS	O	OTHERS	I
after	after	O	O	O	O
the	the	O	O	O	O
injection	injection	O	O	O	O
.	.	O	O	O	O

Various	various	O	O	O	O
ocular	ocular	O	O	O	O
symptoms	symptoms	O	O	O	O
and	and	O	O	O	O
findings	findings	O	O	O	O
caused	caused	O	O	O	O
by	by	O	O	O	O
carboplatin	carboplatin	CHEMICALS	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
were	were	O	O	O	O
seen	seen	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
He	he	O	O	O	O
was	was	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
intravenous	intravenous	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
corticosteroids	corticosteroids	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
glycerin	glycerin	O	O	OTHERS	I
for	for	O	O	O	O
6	6	O	O	O	O
days	days	O	O	O	O
after	after	O	O	O	O
the	the	O	O	O	O
injection	injection	O	O	O	O
.	.	O	O	O	O

Although	although	O	O	O	O
the	the	O	O	O	O
intraocular	intraocular	O	O	O	O
pressure	pressure	O	O	O	O
elevation	elevation	O	O	O	O
caused	caused	O	O	O	O
by	by	O	O	O	O
secondary	secondary	O	O	O	O
acute	acute	O	O	O	O
angle-closure	angle-closure	O	O	O	O
glaucoma	glaucoma	O	DISEASE	OTHERS	I
decreased	decreased	O	O	O	O
and	and	O	O	O	O
ocular	ocular	O	O	OTHERS	I
pain	pain	O	DISEASE	OTHERS	I
diminished	diminished	O	O	O	O
,	,	O	O	O	O
inexorable	inexorable	O	O	O	O
papilledema	papilledema	O	O	OTHERS	I
and	and	O	O	O	O
exudative	exudative	O	O	O	O
retinal	retinal	O	DISEASE	OTHERS	I
detachment	detachment	O	DISEASE	OTHERS	I
continued	continued	O	O	O	O
for	for	O	O	O	O
3	3	O	O	O	O
weeks	weeks	O	O	O	O
.	.	O	O	O	O

Finally	finally	O	O	O	O
,	,	O	O	O	O
6	6	O	O	O	O
weeks	weeks	O	O	O	O
later	later	O	O	O	O
,	,	O	O	O	O
diffuse	diffuse	O	O	O	O
chorioretinal	chorioretinal	O	O	OTHERS	I
atrophy	atrophy	O	DISEASE	OTHERS	I
with	with	O	O	O	O
optic	optic	O	DISEASE	OTHERS	I
atrophy	atrophy	O	DISEASE	OTHERS	I
occurred	occurred	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
vision	vision	O	O	O	O
in	in	O	O	O	O
his	his	O	O	O	O
left	left	O	O	O	O
eye	eye	O	O	O	O
was	was	O	O	O	O
lost	lost	O	O	O	O
.	.	O	O	O	O

CONCLUSION	conclusion	O	O	O	O
:	:	O	O	O	O
When	when	O	O	O	O
performing	performing	O	O	O	O
intracarotid	intracarotid	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
carboplatin	carboplatin	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
we	we	O	O	O	O
must	must	O	O	O	O
be	be	O	O	O	O
aware	aware	O	O	O	O
of	of	O	O	O	O
its	its	O	O	O	O
potentially	potentially	O	O	O	O
blinding	blinding	O	O	O	O
ocular	ocular	O	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
.	.	O	O	O	O

It	it	O	O	O	O
is	is	O	O	O	O
recommended	recommended	O	O	O	O
that	that	O	O	O	O
further	further	O	O	O	O
studies	studies	O	O	O	O
and	and	O	O	O	O
investigations	investigations	O	O	O	O
are	are	O	O	O	O
undertaken	undertaken	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
effort	effort	O	O	O	O
to	to	O	O	O	O
minimize	minimize	O	O	O	O
such	such	O	O	O	O
severe	severe	O	O	O	O
side	side	O	O	O	O
effects	effects	O	O	O	O
.	.	O	O	O	O

